title: Epidemic Clostridium difficile strains demonstrate increased competitive fitness compared to nonepidemic isolates.
abstract: Clostridium difficile infection is the most common cause of severe cases of antibiotic-associated diarrhea (AAD) and is a significant health burden. Recent increases in the rate of C. difficile infection have paralleled the emergence of a specific phylogenetic clade of C. difficile strains (ribotype 027; North American pulsed-field electrophoresis 1 [NAP1]; restriction endonuclease analysis [REA] group BI). Initial reports indicated that ribotype 027 strains were associated with increased morbidity and mortality and might be hypervirulent. Although subsequent work has raised some doubt as to whether ribotype 027 strains are hypervirulent, the strains are considered epidemic isolates that have caused severe outbreaks across the globe. We hypothesized that one factor that could lead to the increased prevalence of ribotype 027 strains would be if these strains had increased competitive fitness compared to strains of other ribotypes. We developed a moderate-throughput in vitro model of C. difficile infection and used it to test competition between four ribotype 027 clinical isolates and clinical isolates of four other ribotypes (001, 002, 014, and 053). We found that ribotype 027 strains outcompeted the strains of other ribotypes. A similar competitive advantage was observed when two ribotype pairs were competed in a mouse model of C. difficile infection. Based upon these results, we conclude that one possible mechanism through which ribotype 027 strains have caused outbreaks worldwide is their increased ability to compete in the presence of a complex microbiota.
authors.affiliation: Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, Michigan, USA.
authors.forename: Catherine D
authors.initials: CD
authors.lastname: Robinson
authors.affiliation: Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, Michigan, USA.
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: Auchtung
authors.affiliation: Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, Michigan, USA.
authors.forename: James
authors.initials: J
authors.lastname: Collins
authors.affiliation: Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, Michigan, USA rbritton@msu.edu.
authors.forename: Robert A
authors.initials: RA
authors.lastname: Britton
mesh_terms: D000818:Animals; D016360:Clostridioides difficile / Q000145:classification* / Q000502:physiology*; D058872:Epidemics; D005243:Feces / Q000382:microbiology; D006801:Humans; D051379:Mice; D008810:Mice, Inbred C57BL; D000091402:Prohibitins; D012336:RNA, Ribosomal, 16S; D021521:Ribotyping
chemical_list: C000717331:PHB2 protein, human; D000091402:Prohibitins; D012336:RNA, Ribosomal, 16S
references.citation: PLoS Comput Biol. 2009 Apr;5(4):e1000352
references.pmid: 19360128
references.citation: Nature. 2012 Jun 13;486(7402):207-14
references.pmid: 22699609
references.citation: CMAJ. 2008 Oct 7;179(8):747-8
references.pmid: 18838443
references.citation: N Engl J Med. 2005 Dec 8;353(23):2442-9
references.pmid: 16322602
references.citation: PLoS Comput Biol. 2013;9(5):e1003059
references.pmid: 23658511
references.citation: Clin Gastroenterol Hepatol. 2009 Aug;7(8):868-873.e2
references.pmid: 19465153
references.citation: Clin Infect Dis. 2007 Jan 15;44(2):238-44
references.pmid: 17173224
references.citation: PLoS One. 2012;7(2):e32381
references.pmid: 22384234
references.citation: PLoS One. 2011;6(12):e27310
references.pmid: 22194782
references.citation: Clin Infect Dis. 2012 Dec;55(12):1661-8
references.pmid: 22972866
references.citation: Curr Protoc Microbiol. 2009 Feb;Chapter 9:Unit9A.1
references.pmid: 19235151
references.citation: J Clin Microbiol. 2013 Sep;51(9):2884-92
references.pmid: 23804381
references.citation: PLoS One. 2011;6(9):e24894
references.pmid: 21949780
references.citation: Bioinformatics. 2011 Aug 15;27(16):2194-200
references.pmid: 21700674
references.citation: Clin Infect Dis. 2013 Apr;56(8):1108-16
references.pmid: 23300235
references.citation: J Antimicrob Chemother. 2003 Jul;52(1):96-102
references.pmid: 12775682
references.citation: Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):9948-52
references.pmid: 18621705
references.citation: Clin Infect Dis. 2010 Jan 15;50(2):194-201
references.pmid: 20025526
references.citation: J Antimicrob Chemother. 2001 Jan;47(1):43-50
references.pmid: 11152430
references.citation: Microb Ecol. 1998 Mar;35(2):180-7
references.pmid: 9541554
references.citation: Johns Hopkins Med J. 1981 Jul;149(1):6-9
references.pmid: 7253364
references.citation: Gut Microbes. 2011 May-Jun;2(3):145-58
references.pmid: 21804357
references.citation: PLoS One. 2008 Mar 19;3(3):e1812
references.pmid: 18350149
references.citation: J Clin Microbiol. 2011 Dec;49(12):4040-6
references.pmid: 21956985
references.citation: Mayo Clin Proc. 2001 Jul;76(7):725-30
references.pmid: 11444405
references.citation: Appl Environ Microbiol. 2010 Aug;76(15):5237-46
references.pmid: 20562281
references.citation: Infect Immun. 2009 Jun;77(6):2367-75
references.pmid: 19307217
references.citation: Infect Control Hosp Epidemiol. 2013 Sep;34(9):961-966
references.pmid: 23917911
references.citation: J Antimicrob Chemother. 2013 May;68(5):1139-43
references.pmid: 23354280
references.citation: Microbiology (Reading). 2010 Nov;156(Pt 11):3216-3223
references.pmid: 20705661
references.citation: Nucleic Acids Res. 2013 May 1;41(10):5175-88
references.pmid: 23571758
references.citation: Gastroenterology. 2008 Dec;135(6):1984-92
references.pmid: 18848941
references.citation: Trends Microbiol. 2012 Jul;20(7):313-9
references.pmid: 22595318
references.citation: Appl Environ Microbiol. 2011 May;77(10):3219-26
references.pmid: 21421784
references.citation: J Bacteriol. 2010 Oct;192(19):4904-11
references.pmid: 20675495
references.citation: Microbiology (Reading). 2010 Nov;156(Pt 11):3270-3281
references.pmid: 20847013
references.citation: Clin Infect Dis. 1992 Oct;15(4):573-81
references.pmid: 1420669
references.citation: Infect Immun. 1986 Nov;54(2):354-8
references.pmid: 3533778
references.citation: Infect Control Hosp Epidemiol. 2011 Apr;32(4):387-90
references.pmid: 21460491
references.citation: CMAJ. 2005 Oct 25;173(9):1037-42
references.pmid: 16179431
references.citation: PLoS One. 2009 Dec 14;4(12):e8230
references.pmid: 20011594
references.citation: PLoS One. 2013 Sep 09;8(9):e73653
references.pmid: 24040011
references.citation: Nucleic Acids Res. 2001 May 1;29(9):e45
references.pmid: 11328886
references.citation: Microbiology (Reading). 2011 Nov;157(Pt 11):3113-3123
references.pmid: 21873406
references.citation: Trends Biotechnol. 2012 Jan;30(1):17-25
references.pmid: 21764163
references.citation: Nat Genet. 2013 Jan;45(1):109-13
references.pmid: 23222960
references.citation: Clin Infect Dis. 2013 Jun;56(11):1589-600
references.pmid: 23463640
references.citation: N Engl J Med. 2005 Dec 8;353(23):2433-41
references.pmid: 16322603
references.citation: Ann Intern Med. 2006 Nov 21;145(10):758-64
references.pmid: 17116920
references.citation: J Clin Microbiol. 2008 Apr;46(4):1530-3
references.pmid: 18287318
references.citation: Anaerobe. 2013 Dec;24:109-16
references.pmid: 23608205
references.citation: J Clin Microbiol. 2013 Jun;51(6):1938-41
references.pmid: 23554188